Zobrazeno 1 - 10
of 266
pro vyhledávání: '"rheumatologic disease"'
Autor:
Jaya Paranilam, Francesco Arcioni, Antonio Franco, Kira Zhi Hua Lai, Joseph Brown, Samantha Kimball-Carroll
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 11, Pp 2227-2253 (2024)
Abstract Introduction The coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented pressure on healthcare systems globally. The lack of quality guidelines on the management of COVID-19 in rheumatologic disease, renal disease, hematologic
Externí odkaz:
https://doaj.org/article/c1015d35641645faa352002e2241ffe9
Autor:
Kira Zhi Hua Lai, Stuart Greenstein, Rajesh Govindasamy, Jaya Paranilam, Joseph Brown, Samantha Kimball-Carroll
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 11, Pp 2255-2283 (2024)
Abstract Introduction The United States Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control (CDC) recommend COVID-19 vaccines for all immunocompromised individuals. Certain disease groups are at increased risk of c
Externí odkaz:
https://doaj.org/article/ac16767a940a44e889cd8f109dd51549
Publikováno v:
EClinicalMedicine, Vol 75, Iss , Pp 102794- (2024)
Summary: Background: Autoimmune diseases are known to be associated with an increased risk of cancer. Whether maternal immune dysregulation can have an impact on the development of haematological malignancies in offspring remains uncertain. Therefore
Externí odkaz:
https://doaj.org/article/d5879203cf514277b7102c8c68288381
Publikováno v:
BMC Rheumatology, Vol 7, Iss 1, Pp 1-10 (2023)
Abstract Background The novel Coronavirus disease (COVID-19) pandemic has represented an evolving global threat with high morbidity and mortality. Patients with autoimmune rheumatic diseases and on immune-suppressing medications may be at increased r
Externí odkaz:
https://doaj.org/article/e8d68356e9834201aa277c4761d7e241
Publikováno v:
Northwestern Medical Journal, Vol 3, Iss 3 (2023)
Aim: In rheumatic diseases, the possibility of developing tuberculosis (TB) increases due to both the disease itself and the biological disease-modifying antirheumatic drugs (bDMARDs) used for treatment. In our study, we aimed to investigate the caus
Externí odkaz:
https://doaj.org/article/7efe07c4a38a4be58188ac5c20c509e7
Publikováno v:
BMC Rheumatology, Vol 6, Iss 1, Pp 1-12 (2022)
Abstract Introduction Immune checkpoint inhibitors (ICIs) enhance the immune system’s ability to target and destroy cancer cells, but this non-specific immune overactivation can result in immune-related adverse events (irAEs). Patients with underly
Externí odkaz:
https://doaj.org/article/afaba46343294acbb5bd1f91bb343475
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 20, Iss 1, Pp 1-8 (2022)
Abstract Background Macrophage activation syndrome (MAS) is a severe and under-recognized complication of rheumatologic diseases. We describe a patient who presented with rapidly progressive, refractory MAS found to have anti-MDA5 antibody Juvenile D
Externí odkaz:
https://doaj.org/article/dc264440ed244c8e92ee3d6f843e0829
Publikováno v:
Фармакоэкономика, Vol 14, Iss 3, Pp 334-341 (2021)
Objective: to assess the expenditure of financial resources allocated for drug provision to the rheumatology department of the state clinical hospital.Material and methods. The materials of the study are statistical reporting data on the expenditure
Externí odkaz:
https://doaj.org/article/19669329de8b40b9bf158208f586ead2